3D EX VIVO PATIENT TISSUE PLATFORM FOR IMMUNOONCOLOGY DRUG TESTING

被引:0
|
作者
Basten, Sander [1 ]
Beztsinna, Nataliia [1 ]
Grillet, Fanny [2 ]
Yan, Kuan [1 ]
Meesters, Niels [1 ]
van der Meer, Donny [2 ]
Spanjaard, Emma [1 ]
Vader, Willemijn [2 ]
Price, Leo [1 ]
机构
[1] CrownBioscience, Leiden, Netherlands
[2] Vitroscan BV, Leiden, Netherlands
关键词
D O I
10.1136/jitc-2022-SITC2022.0199
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
199
引用
收藏
页码:A212 / A212
页数:1
相关论文
共 50 条
  • [1] Expanding the 3D ex vivo patient tissue platform toolbox for (immuno)-oncology drug testing
    Beztsinna, Nataliia
    Basten, Sander
    Aksoy, Ezgi Kaya
    Meesters, Niels
    Timiliotis, Stefanos
    van der Meer, Donny
    Yan, Kuan
    Spanjaard, Emma
    Vader, Willemijn
    Price, Leo S.
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [2] Immunotherapy testing in 3D Ex vivo Patient Tissue Platform with preserved tumor microenvironment
    Beztsinna, Nataliia
    Meesters, Niels
    Daszkiewicz, Lidia
    Grillet, Fanny
    van der Meer, Donny
    Yan, Kuan
    Spanjaard, Emma
    Vader, Willemijn
    Price, Leo
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [3] 'In vitro clinical trials' platform for drug testing in patient-derived ex vivo 3D cultured human tumor tissues
    Beztsinna, N.
    Grillet, F.
    Jariani, A.
    Overkamp, J.
    van der Meer, D.
    Daszkiewicz, L.
    Yan, K.
    Vader, W.
    Price, L.
    [J]. EUROPEAN JOURNAL OF CANCER, 2020, 138 : S59 - S59
  • [4] Novel patient avatar platform for oncology drug testing using 3D ex vivo models derived from fresh patient tumor tissues
    Beztsinna, Nataliia
    Grillet, Fanny
    Meesters, Niels
    van der Meer, Donny
    Daszkiewicz, Lidia
    Yan, Kuan
    Spanjaard, Emma
    Vader, Willemijn
    Price, Leo
    [J]. MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [5] Establishment of a 3D ex-vivo assay as a preclinical drug testing platform for personalized cancer therapy
    Dhar, Sumeer
    Chiovaro, Francesca
    Tanos, Tamara
    Hejhal, Tomas
    Heilemariam, Seife
    Kelm, Jens
    Irmisch, Anja
    Levesque, Mitchell
    [J]. CANCER RESEARCH, 2017, 77
  • [6] Pancreatic cancer 3D organoids: a co-clinical platform for translational research and ex vivo drug testing
    Hussung, S.
    Koehler, K.
    Koehne, N.
    Michalczyk, S.
    Mastroianni, J.
    Fritsch, K.
    Zeiser, R.
    Boerries, M.
    Wittel, U.
    Fritsch, R.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 237 - 237
  • [7] Predicting drug sensitivity in patient derived ex vivo 3D mesothelioma cultures
    Cornelissen, Robin
    Dumouline, Daphne
    Thusen, Janvd
    Basten, Sander
    Grillet, Fanny
    Yan, Kuan
    Price, Leo
    Vader, Willemijn
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [8] A novel 3D ex vivo platform of fresh patient tumor tissue with intact tumor microenvironment for immuno-oncology drug development and biomarker discovery
    Mediavilla-Varela, Melanie
    Page, Melba Marie
    Kreahling, Jenny
    Antonia, Scott
    Altiok, Soner
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [9] 3D tissue models to predict patient-specific response to immunooncology based therapies
    Appleton, Kathryn M.
    Lotstein, Alina
    Guo, Qi
    Elrod, Ashley
    Puls, Larry
    Elder, Jeffrey
    Holmes, Lillia
    Crosswell, Howland E.
    DesRochers, Teresa M.
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [10] Mastospheres as a new 3D ex vivo breast cancer microtumors for preclinical drug testing
    Richon, Sophie
    Cottu, Paul
    Weiswald, Louis-Bastien
    Guinebretiere, Jean-Marc
    Marangoni, Elisabetta
    Assayag, Franck
    Thuleau, Aurelie
    Labiod, Dalila
    Decaudin, Didier
    Bellet, Dominique
    Dangles-Marie, Virginie
    [J]. CANCER RESEARCH, 2012, 72